Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactated Ringer's effect on serum lactate
NCT02950753Phase 1Completed
- Sponsor
- University Medical Center of Southern Nevada
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lactated ringer's solution in sepsis, sponsored by University Medical Center of Southern Nevada. Primary endpoint: Change in Mean Lactate Level. Started Jan 2017; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02950753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950753.